BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35864526)

  • 1. Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation.
    Lim LM; Chung WY; Hwang DY; Yu CC; Ke HL; Liang PI; Lin TW; Cheng SM; Huang AM; Kuo HT
    J Transl Med; 2022 Jul; 20(1):324. PubMed ID: 35864526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic Outcomes of Post-Kidney Transplantation Superficial Urothelial Carcinoma.
    Huang GL; Luo HL; Chen YT; Cheng YT
    Transplant Proc; 2018 May; 50(4):998-1000. PubMed ID: 29731099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.
    Chien CS; Luo HL; Ling CS; Chiang PH; Chen YT; Cheng YT
    Int Urol Nephrol; 2016 Aug; 48(8):1261-1265. PubMed ID: 27193437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response.
    Chen J; Tang Y; Liu H; Sun G; Liu H; Zhao J; Wang Z; Zhang Y; Lou F; Cao S; Qin J; Wang H; Liao B; Zeng H
    Cancer Med; 2023 Dec; 12(24):22370-22380. PubMed ID: 37986697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Moss TJ; Qi Y; Xi L; Peng B; Kim TB; Ezzedine NE; Mosqueda ME; Guo CC; Czerniak BA; Ittmann M; Wheeler DA; Lerner SP; Matin SF
    Eur Urol; 2017 Oct; 72(4):641-649. PubMed ID: 28601352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.
    Tripathi N; Jo Y; Tripathi A; Sayegh N; Li H; Nussenzveig R; Haaland B; Thomas VM; Gupta S; Maughan BL; Swami U; Pal SK; Grivas P; Agarwal N; Sirohi D
    Urol Oncol; 2022 Nov; 40(11):493.e1-493.e7. PubMed ID: 35918248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
    Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
    Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Exome Gene Panel Analysis of a Cohort of Urothelial Bladder Cancer Patients from Sri Lanka.
    Malalasekera A; Neththikumara N; Somasundaram P; Pathirana S; Ediriweera C; Ediriweera D; Goonewardena SA; Perera ND; Abeygunasekara A; Jayasekara RW; Wettasinghe K; Lokuhetty MDS; Dissanayeke VHW
    Asian Pac J Cancer Prev; 2023 May; 24(5):1533-1542. PubMed ID: 37247272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma.
    Chen X; Ou Z; Wang L; Zhang Z; Fan X; Liu H; Wang W; Zhang Y; Zhu J; Liang X; Lou F; Cao S; Yao Y; Wang H; Yao X
    Mol Carcinog; 2022 Mar; 61(3):311-321. PubMed ID: 34729830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of a comprehensive, urothelial carcinoma-specific next-generation sequencing panel in urine cytology and bladder tumor specimens.
    Sun T; Hutchinson L; Tomaszewicz K; Caporelli ML; Meng X; McCauley K; Fischer AH; Cosar EF; Cornejo KM
    Cancer Cytopathol; 2021 Jul; 129(7):537-547. PubMed ID: 33539671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays.
    Pritchard JJG; Hamilton G; Hurst CD; Fraser S; Orange C; Knowles MA; Jones RJ; Leung HY; Iwata T
    Urol Oncol; 2020 Sep; 38(9):737.e1-737.e10. PubMed ID: 32532529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Hydronephrosis in the Native Kidney Is Associated with the Development of De Novo Urinary Bladder Urothelial Carcinoma in Patients with Post-Kidney Transplantation.
    Ho CJ; Huang YH; Hsieh TY; Yang MH; Wang SC; Chen WJ; Sung WW; Chen SL
    Healthcare (Basel); 2023 Apr; 11(9):. PubMed ID: 37174750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
    Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
    Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of somatic tumor sequencing in the treatment of urothelial cancer.
    Wen L; Britton CJ; Garje R; Darbro BW; Packiam VT
    Asian J Urol; 2021 Oct; 8(4):391-399. PubMed ID: 34765446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.
    Yates DR; Rouprêt M; Drouin SJ; Audouin M; Cancel-Tassin G; Comperat E; Bitker MO; Cussenot O
    World J Urol; 2013 Feb; 31(1):53-9. PubMed ID: 23053209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients.
    Yu J; Lee CU; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Cancer Manag Res; 2019; 11():157-166. PubMed ID: 30636892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients.
    Wu CF; Pang ST; Shee JJ; Chang PL; Chuang CK; Chen CS; Liao SK; Weng WH
    Genes Chromosomes Cancer; 2010 Oct; 49(10):928-34. PubMed ID: 20629096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
    Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
    Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.